Definity, echo contrast, induced cardiac arrest: brief review of the literature

Area of Science:

• Cardiology
• Medical Imaging
• Pharmacology

Background:

• Definity (Perflutren lipid microspheres) is an ultrasound contrast agent used in echocardiography.
• The potential for adverse cardiac events, including cardiac arrest, following Definity administration remains a subject of discussion in clinical practice.

Observation:

• A 69-year-old male patient underwent resting echocardiography.
• Immediately after the injection of Definity as a contrast agent, the patient experienced cardiopulmonary arrest.

Findings:

• This case presents a rare, immediate adverse reaction to Definity.
• The event highlights a potential, albeit infrequent, risk associated with Definity administration during echocardiography.

Implications:

• Clinicians should remain vigilant for potential adverse reactions to Definity, even in routine echocardiography.
• Further investigation may be warranted to fully understand the mechanisms and incidence of severe adverse events like cardiac arrest post-Definity.
• This case contributes to the ongoing debate regarding the safety profile of Definity in echocardiography.